Bank of America’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.2K Sell
3,546
-142,458
-98% -$1.39M ﹤0.01% 5626
2025
Q4
$1.68M Sell
146,004
-17,275
-11% -$267K ﹤0.01% 4201
2025
Q3
$3.97M Buy
163,279
+122,260
+298% +$2.04M ﹤0.01% 4229
2025
Q2
$675K Buy
41,019
+22,756
+125% +$393K ﹤0.01% 5545
2025
Q1
$332K Buy
18,263
+9,874
+118% +$282K ﹤0.01% 5880
2024
Q4
$311K Sell
8,389
-6,357
-43% -$243K ﹤0.01% 5860
2024
Q3
$472K Sell
14,746
-18,837
-56% -$1.05M ﹤0.01% 5515
2024
Q2
$2.76M Sell
33,583
-2,811
-8% -$304K ﹤0.01% 4168
2024
Q1
$5.27M Buy
36,394
+27,946
+331% +$2.36M ﹤0.01% 3565
2023
Q4
$778K Sell
8,448
-513
-6% -$52.2K ﹤0.01% 5168
2023
Q3
$1.48M Sell
8,961
-2,126
-19% -$276K ﹤0.01% 4515
2023
Q2
$701K Buy
11,087
+1,536
+16% +$93K ﹤0.01% 5031
2023
Q1
$324K Buy
9,551
+4,386
+85% +$229K ﹤0.01% 5655
2022
Q4
$299K Buy
5,165
+1,178
+30% +$72.8K ﹤0.01% 5700
2022
Q3
$374K Sell
3,987
-4,412
-53% -$628K ﹤0.01% 5600
2022
Q2
$1.87M Buy
8,399
+582
+7% +$195K ﹤0.01% 4365
2022
Q1
$4.3M Sell
7,817
-1,556
-17% -$940K ﹤0.01% 3791
2021
Q4
$6.2M Buy
9,373
+858
+10% +$656K ﹤0.01% 3428
2021
Q3
$7.15M Sell
8,515
-206
-2% -$209K ﹤0.01% 3205
2021
Q2
$11.1M Sell
8,721
-87
-1% -$98.2K ﹤0.01% 2724
2021
Q1
$9.66M Buy
8,808
+940
+12% +$1.24M ﹤0.01% 2755
2020
Q4
$11.2M Sell
7,868
-1,421
-15% -$1.52M ﹤0.01% 2391
2020
Q3
$6.56M Buy
9,289
+418
+5% +$304K ﹤0.01% 2658
2020
Q2
$6.21M Buy
8,871
+239
+3% +$138K ﹤0.01% 2659
2020
Q1
$3.02M Sell
8,632
-29,866
-78% -$21.2M ﹤0.01% 3146
2019
Q4
$24.2M Buy
38,498
+5,760
+18% +$2.82M ﹤0.01% 1725
2019
Q3
$11M Sell
32,738
-1,154
-3% -$370K ﹤0.01% 2409
2019
Q2
$8.8M Buy
33,892
+5,063
+18% +$1.01M ﹤0.01% 2685
2019
Q1
$4.77M Buy
28,829
+1,826
+7% +$297K ﹤0.01% 3206
2018
Q4
$2.92M Buy
27,003
+248
+0.9% +$41.8K ﹤0.01% 3524
2018
Q3
$6.7M Buy
26,755
+63
+0.2% +$13.6K ﹤0.01% 2912
2018
Q2
$5.81M Buy
26,692
+294
+1% +$54.4K ﹤0.01% 3006
2018
Q1
$3.86M Buy
+26,398
New +$4.46M ﹤0.01% 3314

Other funds holding CDLX

Bank of America's CDLX Position: Q1 2026 in Review

Bank of America reduced its Cardlytics (CDLX) stake by 98% in Q1 2026, selling an estimated $1.39M and leaving 3,546 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5626.

Bank of America first reported a position in CDLX in Q1 2018 and has held it in 33 quarters since. The position peaked at $24.2M in Q4 2019. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Bank of America held 3,546 shares of Cardlytics worth $37.2K as of Q1 2026.
  • Bank of America sold 142,458 Cardlytics shares in Q1 2026, an estimated $1.39M.
  • Cardlytics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5626 holding.
  • Bank of America first reported a position in Cardlytics in Q1 2018 and has held it in 33 quarters since.
  • Bank of America's Cardlytics position peaked at $24.2M in Q4 2019.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.